Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $CAH
Date | Price Target | Rating | Analyst |
---|---|---|---|
2/5/2025 | $140.00 → $150.00 | Hold → Buy | Jefferies |
1/8/2025 | $130.00 → $144.00 | Hold → Buy | TD Cowen |
1/7/2025 | $140.00 | In-line → Outperform | Evercore ISI |
1/6/2025 | $132.00 → $145.00 | Neutral → Buy | BofA Securities |
12/13/2024 | $101.00 → $127.00 | Underweight → Equal Weight | Wells Fargo |
12/4/2024 | $139.00 | Outperform | Mizuho |
2/26/2024 | $125.00 | Outperform | Leerink Partners |
2/9/2024 | Hold → Buy | Argus |
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1
DUBLIN, Ohio, March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months. About Cardinal Health Cardinal Hea
Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors
DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2025, to shareholders of record at the close of business on April 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nucle
Cardinal Health upgraded by Jefferies with a new price target
Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously
Cardinal Health upgraded by TD Cowen with a new price target
TD Cowen upgraded Cardinal Health from Hold to Buy and set a new price target of $144.00 from $130.00 previously
Cardinal Health upgraded by Evercore ISI with a new price target
Evercore ISI upgraded Cardinal Health from In-line to Outperform and set a new price target of $140.00
Director Ramakrishna Sudhakar was granted 1,049 shares (SEC Form 4)
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
Director Musslewhite Robert W was granted 1,049 shares (SEC Form 4)
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
New insider Ramakrishna Sudhakar claimed no ownership of stock in the company (SEC Form 3)
3 - CARDINAL HEALTH INC (0000721371) (Issuer)
Cardinal Health Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CARDINAL HEALTH INC (0000721371) (Filer)
SEC Form 10-Q filed by Cardinal Health Inc.
10-Q - CARDINAL HEALTH INC (0000721371) (Filer)
Cardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CARDINAL HEALTH INC (0000721371) (Filer)
Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors
DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e
RPM Announces Appointment of Three New Board Members
RPM International Inc. (NYSE:RPM) today announced the appointment of three individuals, Craig S. Morford, Christopher L. Mapes and Julie A. Beck, to its board of directors. These appointments reflect RPM's ongoing commitment to expanding the expertise, diversity and leadership capabilities of its board as the company continues to drive long-term growth and shareholder value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113146614/en/Christopher L. Mapes (Photo: Business Wire) The appointments of Mr. Morford and Mr. Mapes are effective immediately, and Ms. Beck's term is set to commence on April 7, 2025. With these additions,
Bob Azelby to join Cardinal Health Board of Directors
DUBLIN, Ohio, Feb. 28, 2024 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert "Bob" Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years of experience, including as a Chief Executive Officer and board member for large, matrixed organizations in the biopharmaceutical, oncology and other specialty industries. Mr. Azelby has previously served as President and Chief Executive Officer of Eliem Therapeutics, and prior to Eliem, he was the Chief Executive Officer of Alder BioPharmac
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 3, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2025, to shareholders of record at the close of business on April 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nucle
Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook
Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expirationGAAP1 operating earnings were $549 million; GAAP diluted EPS was $1.65Non-GAAP operating earnings increased 9% to $635 million, driven by the Pharmaceutical and Specialty Solutions segment; non-GAAP diluted EPS increased 2% to $1.93Fiscal year 2025 non-GAAP EPS guidance2 raised to $7.85 to $8.00, from $7.75 to $7.90Company announces the completion of its acquisition of 73% ownership of GI AllianceDUBLIN, Ohio, Jan. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported second quarter fiscal year 2025 revenues of $55.3 billion, a decrea
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 5, 2024 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2025 to shareholders of record at the close of business on January 2, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc
SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)
SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)